高级检索
当前位置: 首页 > 详情页

Combination of size-exclusion chromatography and ion exchange adsorption for improving the proteomic analysis of plasma-derived extracellular vesicles

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Research Center, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China. [2]The Center for Heart Development, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Sciences, Hunan Normal University, Changsha, Hunan, P. R. China. [3]Clinical Laboratory, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China. [4]Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
出处:
ISSN:

关键词: extracellular vesicles ion exchange adsorption lipoprotein mass spectrometry size-exclusion chromatography

摘要:
Extracellular vesicles (EVs) are lipid membrane vesicles released by live cells that carry a variety of biomolecules, including nucleic acids, lipids, and proteins. Recently, proteins in plasma-derived EVs have emerged as novel biomarkers with essential functions in the diagnosis and prognosis of human diseases. However, the current methods of isolating EVs from plasma often lead to coisolated impurities in biological fluids. Therefore, before performing any research protocol, the process of extracting EVs from plasma for proteomic analysis must be optimized. In this study, two EV isolation strategies, size exclusion chromatography (SEC) and SEC combined with ion exchange adsorption (SEC + IEA), were compared in terms of the purity and quantity of protein in EVs. Our results demonstrated that, compared to single-step SEC, SEC combined with IEA could produce plasma-derived EVs with a higher purity by decreasing the abundance of lipoprotein. Additionally, with MS analysis, we demonstrated that the combination approach maintained the stability and improved the purity of EVs in many plasma samples. Furthermore, by combining SEC with IEA, more cancer-associated proteins were detected in the plasma of various cancer samples.© 2023 Wiley-VCH GmbH.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2023]版:
大类 | 4 区 生物学
小类 | 4 区 生化研究方法 4 区 生化与分子生物学
最新[2025]版:
大类 | 3 区 生物学
小类 | 3 区 生化研究方法 4 区 生化与分子生物学
JCR分区:
出版当年[2023]版:
Q2 BIOCHEMICAL RESEARCH METHODS Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2024]版:
Q1 BIOCHEMICAL RESEARCH METHODS Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版] 出版后一年[2024版]

第一作者:
第一作者机构: [1]Research Center, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
共同第一作者:
通讯作者:
通讯机构: [1]Research Center, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China. [*1]Research Center, the Fourth Hospital of Hebei Medical University, 12 JianKang road, Shijiazhuang, 050000, Hebei, P. R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号